Exemplos de uso de Caution is advised when em Inglês e suas traduções para o Português
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
Caution is advised when unforeseen transfers, into the.
If the patient is experiencing fatigue, caution is advised when driving a car or operating machinery.
Caution is advised when combining stiripentol with other drugs that inhibit or induce one or more of these enzymes.
Some patients have experienced dizziness, fatigue or vasovagal reactions;therefore caution is advised when driving or operating machines.
Therefore, caution is advised when administering Eurartesim to these patients see section 4.4.
Possible implications for the in vivo situation have not been investigated, but caution is advised when cangrelor is to be combined with a BCRP substrate.
Therefore, caution is advised when Jentadueto is used in combination with a sulphonylurea and/or insulin.
Enzalutamide has not been evaluated in patients with severe renal impairment(CrCL< 30 mL/min) orend-stage renal disease, and caution is advised when treating these patients.
Caution is advised when combining stiripentol with other substances that inhibit or induce one or more of these enzymes.
Sufentanil is excreted in human milk when applied intravenously;therefore caution is advised when Zalviso is administered to breast-feeding women.
Caution is advised when the elderly use this product, because they may be more sensitive to the effects of the drug.
Due to reports of cutaneous bleeding abnormalities with SSRIs(e.g., paroxetine,sertraline and citalopram), caution is advised when administering SSRIs with Possia as this may increase the risk of bleeding.
Caution is advised when Effentora is coadministered with drugs that affect the serotoninergic neurotransmitter systems.
Due to reports of cutaneous bleeding abnormalities with SSRIs(e.g. paroxetine,sertraline and citalopram), caution is advised when administering SSRIs with ticagrelor as this may increase the risk of bleeding.
Caution is advised when Agenerase is used concomitantly with PDE5 inhibitors(e.g. sildenafil and vardenafil) see section 4.5.
Since bupropion is extensively metabolised, caution is advised when naltrexone/ bupropion is co-administered with medicinal products known to inhibit metabolism(e.g. valproate), as these may affect its clinical efficacy and safety.
Caution is advised when PecFent is coadministered with medicinal products that affect the serotoninergic neurotransmitter systems.
Since bupropion is extensively metabolised, caution is advised when naltrexone/ bupropion is co-administered with medicinal products known to induce CYP2B6(e.g., carbamazepine, phenytoin, ritonavir, efavirenz) as these may affect the clinical efficacy of naltrexone/ bupropion.
Caution is advised when administering with medicinal products activated by or metabolised by CYP2D6, particularly with medicinal products that have a narrow therapeutic index.
Therefore, caution is advised when daptomycin is co- administered with any other medicinal product known to reduce renal filtration.
Caution is advised when bisphosphonates are administered with aminoglycosides, since both substances can lower serum calcium levels for prolonged periods.
However caution is advised when methotrexate is administered concurrently with NSAIDs, because NSAID administration may result in increased plasma levels of methotrexate.
Caution is advised when SonoVue is administered to patients with clinically significant pulmonary disease, including severe chronic obstructive pulmonary disease.
Caution is advised when leflunomide is given together with drugs, other than NSAIDs, metabolised by CYP2C9 such as phenytoin, warfarin, phenprocoumon and tolbutamide.
Caution is advised when administering Cubicin to patients who already have some degree of renal impairment(creatinine clearance< 80 ml/min) before commencing therapy with Cubicin.
Therefore, caution is advised when CYP2B6 substrates, especially medicinal products with a narrow therapeutic index such as cyclophosphamide, are co-administered with CRESEMBA.
Caution is advised when warfarin, acenocoumarol, tolbutamide, phenytoin or other active substances that are known to be metabolised by CYP2C9 are administered with IVEMEND.
Caution is advised when Zometa is administered with medicinal products known to cause hypocalcaemia, as they may have a synergistic effect resulting in severe hypocalcaemia see section 4.5.
Caution is advised when warfarin, acenocoumarol, tolbutamide, phenytoin or other medicinal products that are known to be metabolised by CYP2C9 are administered during this time period.
Caution is advised when zoledronic acid is administered with medicinal products known to cause hypocalcaemia, as they may have a synergistic effect resulting in severe hypocalcaemia see section 4.5.